| Literature DB >> 29601856 |
Ryan L Clark1, Laura L McGinley2, Hugh M Purdy3, Travis C Korosh4, Jennifer L Reed5, Thatcher W Root6, Brian F Pfleger7.
Abstract
Cyanobacteria are photosynthetic microorganisms whose metabolism canpan> be modified through genetic enginpan>eerinpan>g for production of a wide variety of mopan> class="Chemical">lecules directly from CO2, light, and nutrients. Diverse molecules have been produced in small quantities by engineered cyanobacteria to demonstrate the feasibility of photosynthetic biorefineries. Consequently, there is interest in engineering these microorganisms to increase titer and productivity to meet industrial metrics. Unfortunately, differing experimental conditions and cultivation techniques confound comparisons of strains and metabolic engineering strategies. In this work, we discuss the factors governing photoautotrophic growth and demonstrate nutritionally replete conditions in which a model cyanobacterium can be grown to stationary phase with light as the sole limiting substrate. We introduce a mathematical framework for understanding the dynamics of growth and product secretion in light-limited cyanobacterial cultures. Using this framework, we demonstrate how cyanobacterial growth in differing experimental systems can be easily scaled by the volumetric photon delivery rate using the model organisms Synechococcus sp. strain PCC7002 and Synechococcus elongatus strain UTEX2973. We use this framework to predict scaled up growth and product secretion in 1L photobioreactors of two strains of Synechococcus PCC7002 engineered for production of l-lactate or L-lysine. The analytical framework developed in this work serves as a guide for future metabolic engineering studies of cyanobacteria to allow better comparison of experiments performed in different experimental systems and to further investigate the dynamics of growth and product secretion.Entities:
Keywords: Cyanobacteria; Light-limitation; Photobioreactor; Photosynthetic efficiency; Scale-up
Mesh:
Substances:
Year: 2018 PMID: 29601856 PMCID: PMC5984190 DOI: 10.1016/j.ymben.2018.03.017
Source DB: PubMed Journal: Metab Eng ISSN: 1096-7176 Impact factor: 9.783